In medicine, BMT stands for bone marrow transplant. It’s a procedure in which healthy blood-forming stem cells are infused into a patient to replace bone marrow that has been damaged or destroyed, typically by high-dose chemotherapy or radiation. The procedure is used to treat a range of serious blood cancers and other disorders, and it remains one of the most intensive treatments in modern medicine.
Why a BMT Is Performed
Bone marrow transplants are most commonly used for cancers that affect blood cells: leukemia, lymphoma, multiple myeloma, and myelodysplastic syndromes. But the list of conditions goes well beyond cancer. BMT can also treat bone marrow failure syndromes, aplastic anemia, sickle cell disease, immune deficiencies, and certain inborn errors of metabolism. In children, it may be used for neuroblastoma, Ewing sarcoma, and brain tumors that have returned after initial treatment.
The basic logic behind the procedure is straightforward. Many of these diseases originate in the bone marrow or blood cells. Powerful chemotherapy or radiation can wipe out the diseased cells, but it also destroys the healthy marrow that produces blood. A transplant replaces that marrow with functioning stem cells so the body can rebuild its blood supply from scratch.
Types of Bone Marrow Transplant
There are two main types, defined by where the stem cells come from.
An autologous transplant uses your own stem cells. They’re collected from your body before high-dose chemotherapy, stored, and then infused back afterward. Because the cells are yours, there’s no risk of your body rejecting them. This type relies entirely on the chemotherapy itself to control the disease.
An allogeneic transplant uses stem cells from a donor, either a family member or an unrelated match found through a registry. This type carries more risk, but it also offers something autologous transplants cannot: a graft-versus-tumor effect. The donor’s immune cells can recognize and attack remaining cancer cells in your body, providing an ongoing layer of disease control. The tradeoff is a significant complication called graft-versus-host disease, where those same donor immune cells attack your healthy tissues.
A third, much rarer type is a syngeneic transplant, which uses stem cells from an identical twin. It avoids immune rejection entirely but also lacks the graft-versus-tumor benefit.
How Stem Cells Are Collected
Despite the name “bone marrow transplant,” the stem cells don’t always come from bone marrow. There are two primary collection methods.
A traditional bone marrow harvest involves drawing marrow directly from the hip bone under anesthesia. Donors who go this route tend to experience more pain at the donation site, more days of restricted activity, and are more likely to need hospitalization. Back pain is the most common complaint, reported by about 23% of bone marrow donors.
The more common approach today is peripheral blood stem cell collection. The donor receives injections of a growth factor for several days beforehand, which coaxes stem cells out of the marrow and into the bloodstream. The cells are then filtered from the blood through an IV line. This method involves less post-donation pain and fewer overall side effects, though the growth factor injections themselves can cause bone pain and discomfort in the days leading up to collection.
What Happens During the Procedure
A BMT unfolds in phases, starting well before the actual transplant day.
The first phase is called conditioning. You receive high-dose chemotherapy, sometimes combined with total body radiation, over several days. The goal is twofold: destroy the diseased cells and suppress your immune system enough that it won’t reject the new stem cells. For older patients or those with other health conditions, doctors may use a reduced-intensity conditioning regimen that relies more heavily on the donor cells’ immune effect rather than brute-force chemotherapy.
The transplant itself is surprisingly anticlimactic. The stem cells are infused through an IV line, much like a blood transfusion. From there, the cells travel through your bloodstream to the bone marrow, where they begin to grow and produce new blood cells. This process, called engraftment, is the critical milestone. During the waiting period, which typically spans two to four weeks, your blood counts drop to dangerously low levels, leaving you highly vulnerable to infection and bleeding.
Recovery and Isolation
The weeks and months after a BMT require strict precautions because your rebuilt immune system is extremely fragile. Before you return home, your living space should be thoroughly cleaned with disinfectants, including drapes, upholstered furniture, and air conditioning filters. Someone else should handle the cleaning.
Daily life changes significantly during recovery. You’ll need to keep doors and windows closed as much as possible, remove live indoor plants, and avoid gardening or contact with soil. Cooked food left at room temperature for more than two hours should be thrown away, and leftovers need thorough reheating. A food thermometer becomes a practical tool during this period.
Pets require special consideration. Reptiles, chickens, ducks, rodents, and exotic animals may need to be temporarily rehomed. Even with cats and dogs, you shouldn’t clean litter boxes or pet beds, sleep with your pet, or risk bites and scratches. Pets should be up to date on vaccines and potentially tested for parasites.
Graft-Versus-Host Disease
For patients who receive an allogeneic transplant, graft-versus-host disease (GVHD) is the most significant complication. It occurs when the donor’s immune cells attack the recipient’s body, and it affects roughly 35% to 50% of allogeneic transplant recipients.
GVHD primarily targets three organs. On the skin, it appears as a rash or dermatitis that can progress to blisters. In the liver, it causes inflammation and jaundice. In the gut, it triggers crampy abdominal pain, diarrhea, nausea, and vomiting. Some patients experience involvement in just one of these areas, while others develop problems in all three. GVHD can occur in an acute form within the first few months or develop into a chronic condition that persists for years.
Long-Term Health After a BMT
Even after a successful transplant, the effects on your body extend well beyond the initial recovery. BMT survivors face elevated risks for cardiovascular disease, lung problems, thyroid dysfunction, liver and kidney issues, bone loss, and secondary cancers that can appear years later. Infertility is common, and iron overload from frequent blood transfusions during treatment may need to be addressed.
Because of these risks, long-term monitoring becomes a routine part of life. Thyroid function is typically checked annually. Patients who take steroid medications for extended periods are screened for osteoporosis. Viral monitoring, particularly for cytomegalovirus, may continue for a year or longer in high-risk patients. Neuropsychological effects, including cognitive changes and emotional challenges, are also recognized late effects that many survivors experience.
The intensity of a bone marrow transplant, from conditioning through years of follow-up, reflects the seriousness of the diseases it treats. For many patients with aggressive blood cancers or life-threatening marrow disorders, BMT offers the best or only chance at long-term remission.